Categoria: Pesquisa

A SOM Biotech conclui o processo de recrutamento no estudo de Fase IIb do tratamento da coreia na doença de Huntington

SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical […]

A Prilenia planeia apresentar um pedido de autorização de introdução no mercado na UE para a pridopidina na doença de Huntington

Prilenia announced today that they plan to submit a Marketing Authorization Application in the EU for the use of Pridopidine in the treatment of Huntington’s Disease. According to Dr. Michael […]

A descoberta representa uma nova esperança para os doentes de DH

Scientists from the Weizmann Institute in Israel have published the results of an animal study which holds tremendous promise for the treatment of Huntington’s Disease.  They have discovered that two […]

uniQure anuncia novidades sobre os ensaios clínicos de fase I/II da terapia genética AMT-130 para o tratamento da doença de Huntington

~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to an inclusion criteria-matched natural history of the disease ~ ~ Mean […]

PTC Therapeutics partilha dados provisórios positivos do ensaio clínico PIVOT-HD em doentes com doença de Huntington

June 21, 2023 PDF Version – Dose-dependent lowering of blood Huntingtin (HTT) protein levels at 12 weeks –– Favorable tolerability profile with no treatment-related serious adverse events or NfL spikes –  – Conference […]

uniQure anuncia novidades sobre o ensaio clínico de fase I/II nos EUA da terapia genética AMT-130 para o tratamento da doença de Huntington

~ AMT-130 continues to be generally well-tolerated across both dose cohorts ~ ~ Patients treated with AMT-130 show preserved function compared to baseline and clinical benefits relative to natural history […]

A PRILENIA ANUNCIA OS RESULTADOS DO ESTUDO PROOF-HD: RESULTADOS PROMETEDORES, MAS MISTOS!

Today, April 25th, Prilenia announced results from the PROOF-HD clinical trial for Huntington’s Disease. Some of the participants showed significant benefits from the Pridopidine drug, while others did not benefit at all.  This […]

Prilenia Atinge Última Visita do Doente na Fase 3 Estudo Clínico PROOF-HD para a Doença de Huntington

O PROOF-HD é o único estudo de fase tardia na doença de Huntington que visa a progressão clínica; os resultados iniciais são esperados no início do segundo trimestre de 2023 NAARDEN, Holanda e WALTHAM, Massachusetts, 28 de março de 2023 - Prilenia Therapeutics B.V., uma [...]

Roche/ Genentech actualização sobre o estudo GENERATION HD2

Roche/ Genentech announce that Phase II GENERATION HD2 study is now open. This is great news for the international community since it is planned to run in 15 countries (Argentina, […]

Novartis termina o estudo VIBRANT-HD

Novartis shared today the difficult news that they are stopping the VIBRANT-HD study of Branaplam, after some participants devoloping side effects. Read the full Novartis letter Even if this news […]